→Appendix 1: polystyrene sulfonate
PDF page 1139
Appetite decreased. constipation
(discontinue—avoid magnesium-containing laxatives).
diarrhoea. electrolyte imbalance. epigastric discomfort.
gastrointestinal disorders. gastrointestinal necrosis (in
combination with sorbitol). hypercalcaemia (in dialysed
patients and occasionally in those with renal impairment).
increased risk of infection. nausea. vomiting
PDF page 1139
Manufacturers advise use only if potential
benefit outweighs risk—no information available.
PDF page 1139
Manufacturers advise use only if
potential benefit outweighs risk—no information
available.
PDF page 1139
Monitor for electrolyte
disturbances (stop if plasma-potassium concentration
below 5 mmol/litre).
PDF page 1139